Janus Henderson Group
ONC

Janus Henderson Group’s BeOne Medicines Ltd ONC Stock Holding History

Janus Henderson Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,701
Closed -$321K – 2704
2022
Q1 		$321K Buy
+1,701
New +$362K ﹤0.01% 2178
2021
Q4 		– Sell
-882
Closed -$320K – 2598
2021
Q3 		$320K Sell
882
-345
-28% -$113K ﹤0.01% 1856
2021
Q2 		$421K Sell
1,227
-349
-22% -$116K ﹤0.01% 1457
2021
Q1 		$549K Buy
+1,576
New +$522K ﹤0.01% 1339
2020
Q4 		– Sell
-95,096
Closed -$27.2M – 1445
2020
Q3 		$27.2M Buy
95,096
+88,928
+1,442% +$20.9M 0.01% 641
2020
Q2 		$1.16M Sell
6,168
-596
-9% -$97K ﹤0.01% 1103
2020
Q1 		$833K Sell
6,764
-354,625
-98% -$55.5M ﹤0.01% 1121
2019
Q4 		$59.9M Sell
361,389
-161,175
-31% -$26.8M 0.03% 529
2019
Q3 		$64M Sell
522,564
-7,526
-1% -$1,000K 0.03% 502
2019
Q2 		$65.7M Buy
530,090
+57,466
+12% +$7.29M 0.04% 507
2019
Q1 		$62.4M Sell
472,624
-7,389
-2% -$997K 0.03% 524
2018
Q4 		$67.3M Buy
480,013
+37,506
+8% +$4.97M 0.04% 458
2018
Q3 		$76.2M Buy
442,507
+54,593
+14% +$9.18M 0.04% 466
2018
Q2 		$59.6M Sell
387,914
-558,250
-59% -$99.6M 0.03% 502
2018
Q1 		$159M Buy
946,164
+518,841
+121% +$70.3M 0.09% 253
2017
Q4 		$41.8M Buy
427,323
+101,164
+31% +$9.26M 0.03% 588
2017
Q3 		$33.7M Buy
+326,159
New +$24.3M 0.02% 612

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Janus Henderson Group's ONC Position: Q2 2022 in Review

Janus Henderson Group sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 1,701 shares — an estimated $321K sold.

Janus Henderson Group first reported a position in ONC in Q3 2017 and held it in 17 quarters. The position peaked at $159M in Q1 2018. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

  • Janus Henderson Group reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
  • Janus Henderson Group sold 1,701 BeOne Medicines Ltd shares in Q2 2022, an estimated $321K.
  • Janus Henderson Group first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 17 quarters.
  • Janus Henderson Group's BeOne Medicines Ltd position peaked at $159M in Q1 2018.
  • 235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.